[Hopespringpcsg] FW: ASCO GU: Drug Delays Prostate Cancer Metastasis By 2 Years

[Glen Tolhurst]

Hi all:
See below for an interesting article.
Thx.
Glen

Sent from Mail for Windows 10

From: Cancer Network
Sent: February 8, 2018 10:03 AM

Subject: ASCO GU: Drug Delays Prostate Cancer Metastasis By 2 Years

Docetaxel plus hormone therapy improves QOL in prostate cancer patients
To view this email as a web page, click here.




ASCO GU 2018   |  February 8, 2018 
  
Apalutamide Delays Metastasis in Prostate Cancer 
Apalutamide was well-tolerated and associated with delayed metastasis in men with high-risk castration-resistant prostate cancer that has become refractory to conventional hormone therapy, according to an early interim analysis of the phase III SPARTAN clinical trial. 
 Read more  
ADVERTISEMENT 


  
Docetaxel Plus Hormone Therapy Improves QOL in Prostate Cancer Patients 
Adding docetaxel chemotherapy to frontline hormone therapy improves quality of life and may reduce the need for subsequent treatment, according to an analysis from the STAMPEDE trial.

 Read more  


  
First-Line Atezolizumab/Bevacizumab Well-Tolerated in Metastatic RCC 
Adding atezolizumab and bevacizumab to standard care was tolerable and slowed tumor growth in patients with previously untreated clear-cell or sarcomatoid-histology metastatic renal cell carcinoma when compared to sunitinib, according to findings from a phase III study.

 Read more  


  

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: UBM Medica, a division of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
NEWSLETTER
Forward to a Friend 
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Subscribe to Print
Contact Us 
CONNECT
      


  

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20180210/78771ad5/attachment.html>